Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep:153:113401.
doi: 10.1016/j.biopha.2022.113401. Epub 2022 Jul 16.

A Chinese classical prescription Guizhi-Fuling Wan in treatment of ovarian cancer: An overview

Affiliations
Free article
Review

A Chinese classical prescription Guizhi-Fuling Wan in treatment of ovarian cancer: An overview

XueZhen Wang et al. Biomed Pharmacother. 2022 Sep.
Free article

Abstract

Ovarian cancer is one of the three most common female reproductive system cancers and has been a hot topic in the field of gynecology and oncology. Currently, surgery with chemotherapy is the common strategy in treatment of ovarian cancer, while it is always accompanied by drug resistance and some adverse effects. Over the past few years, traditional Chinese medicine (TCM) has been embraced by a large population of clinicians and researchers due to its high efficiency, low toxicity and minor side effects. Guizhi-Fuling Wan as a classical TCM formula has manifested certain efficacy in treating ovarian cancer. This article intends to further study the role and mechanism of Guizhi-Fuling Wan in treatment of ovarian cancer and explore the effective chemical components contained in the herbs of the formula. To this end, we reviewed the previous clinical studies and experiments to analyze the molecular mechanisms, pharmacological effects, active chemical components and their targets of action in treatment of ovarian cancer, thereby providing a theoretic basis for future studies and practices.

Keywords: Clinical application; Guizhi-Fuling Wan; Molecular mechanism; Ovarian cancer; Pharmacology.

PubMed Disclaimer

Conflict of interest statement

Conflict of interests The authors have declared that they have no competing interests.

LinkOut - more resources